/

Usuario:

1.2.1.3 Libro Científico

Por favor, utilice la liga Insertar nuevo registro para agregar registros, la liga Ver para verificar los datos, si se requiere algún cambio, presione la liga Editar; en caso de querer eliminar toda la información del registro, presione la liga Borrar. Al final presione el botón Aceptar o Confirmar para registrar los cambios

Página anterior Registro anterior Registro siguiente


Nombre del Modulo  1.2.1.3 Libro científico
Titulo  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Subtitulo  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Colección  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Número de Páginas  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Edición  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
ISBN  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Pais  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Idioma  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Editorial  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Tiraje  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Fecha de Aceptación  0000-00-00
Fecha de Publicación  0000-00-00
Coautores  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Año de la Actividad  2011
Observaciones  A Second Class stamp http://xnxx-sexxnxx.in.net/sitemaps/2.html boobs McHutchison said data on another Gilead all-oral regimen - sofosbuvir combined with NS5A inhibitor ledipasvir - will be presented at a medical meeting next April. The company plans to
Proyecto de Investigacion Asignado